Revelation Biosciences Financials - Benzinga

Revelation Biosciences Inc

REVBNASDAQ

Trade with Public

Trade with Public

$1.13

-0.01-0.88%

Last update: Aug 10, 3:32 PM

Earnings: Q2 2026 Earnings were released on Thu Aug 6th, after the market close

Overview News Earnings Forecast EventsFinancialsSentiment Ownership Compare Stock Report

Revelation Biosciences Financials

Revelation Biosciences (REVB) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Revelation Biosciences Q2 EPS $(0.87) Beats $(0.88) Estimate

Revelation Biosciences (NASDAQ:REVB) reported quarterly losses of $(0.87) per share which beat the analyst consensus estimate of $(0.88) by 1.14 percent. This is a 87.59 percent increase over losses of $(7.01) per share

Benzinga Newsdesk

PRO
Revelation Biosciences Q1 EPS $(2.71) Misses $(1.55) Estimate

Revelation Biosciences (NASDAQ:REVB) reported quarterly losses of $(2.71) per share which missed the analyst consensus estimate of $(1.55) by 74.84 percent. This is a 89.31 percent increase over losses of $(25.34) per

Benzinga Newsdesk

PRO
Revelation Biosciences Q4 EPS $(1.65) Misses $(0.96) Estimate

Revelation Biosciences (NASDAQ:REVB) reported quarterly losses of $(1.65) per share which missed the analyst consensus estimate of $(0.96) by 71.88 percent. This is a 97.24 percent increase over losses of $(59.76) per

Benzinga Newsdesk

Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Decline After 2 Consecutive Days Of Gains—Intel, CSX In Focus (UPDATED)

US stock futures slightly down after 2 days of gains. Trump withdraws tariffs on EU, while Q3 GDP exceeds estimates.

Vishaal Sanjay

PRO
Revelation Biosciences Q3 EPS $(1.77) Misses $(1.33) Estimate

Benzinga Newsdesk

PRO
Revelation Biosciences Q2 EPS $(7.01) Misses $(1.49) Estimate

Revelation Biosciences (NASDAQ:REVB) reported quarterly losses of $(7.01) per share which missed the analyst consensus estimate of $(1.49) by 372.05 percent. This is a 97.15 percent increase over losses of $(246.24) per

Benzinga Newsdesk